Performance Forecast - The company expects to achieve a net profit attributable to shareholders of 320 million to 400 million yuan for the first half of 2025, indicating a turnaround from previous losses [1] - The company anticipates a net profit attributable to shareholders, excluding non-recurring gains and losses, to be between -20 million and -30 million yuan [1] Previous Year Comparison - In the same period last year, the total profit was -660.34 million yuan, with a net profit attributable to shareholders of -540.01 million yuan, and a net profit excluding non-recurring gains and losses of -603.60 million yuan [1] - The earnings per share for the previous year was -0.62 yuan [1] Reasons for Turnaround - The expected turnaround in performance is primarily due to a significant decrease in interest expenses and effective cost management strategies, including procurement and supply chain cooperation that reduced the costs of key feed raw materials [1] - The main business segments, including pig farming, feed, and slaughtering, have shown recovery and restructuring, laying a foundation for improved profitability [1] - The second quarter is expected to show a positive net profit attributable to shareholders, excluding non-recurring gains and losses, although the half-year figure is still projected to be negative due to depreciation and amortization costs from idle pig farms and feed factories, which are estimated to reduce profits by approximately 50 million yuan [1]

（一）业绩预告期间 2025 年 1 月 1 日至 2025 年 6 月 30 日。 证券代码：603363 证券简称：傲农生物 公告编号：2025-080 福建傲农生物科技集团股份有限公司 2025 年半年度业绩预盈公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、本期业绩预告情况 （二）业绩预告情况 经公司财务部门初步测算： 1、预计 2025 年半年度实现归属于上市公司股东的净利润为 32,000.00 万元到 40,000.00 万元。 本期业绩预告的具体适用情形：净利润实现扭亏为盈 公司预计 2025 年半年度实现归属于上市公司股东的净利润为 32,000.00 万 元到 40,000.00 万元。 公司预计 2025 年半年度实现归属于上市公司股东的扣除非经常性损益的 净利润为-2,000.00 万元到-3,000.00 万元。 本次业绩预告数据仅为初步核算数据，具体数据以公司正式披露的 2025 年半年度报告为准，敬请投资者注意投资风险。 2、预计 2025 年半年度实现归属于上市公司股东 ...

Core Viewpoint - The company disclosed its main operational data for the pig farming business in June 2025, highlighting significant increases in both sales volume and inventory levels compared to the previous year [1][2]. Group 1: Sales and Inventory Data - The sales volume of live pigs in June 2025 was 14.24 million heads, representing a year-on-year increase of 20.46% [2]. - The inventory level at the end of June 2025 was 54.70 million heads, with a year-on-year increase of 20.70% [2]. - The month-end inventory increased by 1.98% compared to May 2025 and was up 6.64% from December 2024 [2]. Group 2: Operational Strategy - The company is actively optimizing its pig farming capacity by adjusting its farming layout, scale, and breed structure [2]. - The company will continue to adhere to a strategy focused on stability and cost reduction, concentrating resources on developing advantageous production capacity [2].

Core Points - The company has reported an increase in litigation and arbitration cases since March 10, 2025, totaling 201.15 million yuan [1][2] - The total amount involved in these new cases is 201.15 million yuan, which represents a significant portion of the company's audited net assets [2] - The company is involved in both plaintiff and defendant roles in these cases, with 25.32 million yuan as plaintiffs and 175.97 million yuan as defendants [2] Summary of New Litigation and Arbitration Cases - The company has added 123 new litigation and arbitration cases since March 10, 2025, with a total amount of 201.15 million yuan [2] - Of the total amount, 17.59 million yuan pertains to unresolved cases, while 25.27 million yuan relates to resolved cases [2] - The company has a significant number of cases exceeding 10 million yuan, totaling 110.11 million yuan, while cases below 10 million yuan account for 91.04 million yuan [2] Recent Litigation Details - A recent case involves the Shanghai Jinma Water Products Cooperative as the plaintiff against Jiangsu Honggao Feed Co., Ltd., seeking the delivery of 38.59 tons of crab feed and a refund of 199,600 yuan if the contract is not fulfilled [3] - The plaintiff also requests interest on the refund amount calculated from January 3, 2024, amounting to 12,621.27 yuan as of February 19, 2025 [3] - The company acknowledges that the impact of these litigations on current and future profits remains uncertain due to ongoing proceedings [3]

2025 年 6 月养殖业务主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 福建傲农生物科技集团股份有限公司（以下简称"公司"）现将 2025 年 6 月养殖业务主要经营数据披露如下： 一、2025 年 6 月养殖业务主要经营数据 单位：万头 | 主要产品 | 销售量 | 库存量 | 销售量同比 增减（%） | 库存量同比 增减（%） | | --- | --- | --- | --- | --- | | 生猪 | 14.24 | 54.70 | +20.46 | +20.70 | 证券代码：603363 证券简称：傲农生物 公告编号：2025-078 福建傲农生物科技集团股份有限公司 福建傲农生物科技集团股份有限公司董事会 2025 年 7 月 8 日 单位：万头 月份 当月销售量 当年累计销售量 期末库存量 2024 年 6 月 11.82 138.03 45.32 2024 年 7 月 12.55 150.58 47.54 2024 年 8 月 11.83 162.41 50.69 2024 年 9 月 ...

证券代码：603363 证券简称：傲农生物 公告编号：2025-079 福建傲农生物科技集团股份有限公司 关于新增涉及诉讼、仲裁事项的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 案件所处的诉讼（仲裁）阶段：公司 2025 年 3 月 10 日至今新增诉讼（仲 裁）金额 20,115.33 万元，其中尚未结案诉讼、仲裁案件金额为 17,588.20 万元， 已结案诉讼、仲裁案件金额为 2,527.13 万元。 上市公司所处的当事人地位：原告、被告；申请人、被申请人等。 涉案的金额：公司 2025 年 3 月 10 日至今新增诉讼（仲裁）金额 20,115.33 万元。 是否会对上市公司损益产生负面影响：鉴于部分诉讼、仲裁案件尚未开 庭审理或尚未结案或尚未执行完毕，上述事项对公司本期利润或期后利润的影响 存在不确定性。敬请投资者理性投资，注意投资风险。 根据《上海证券交易所股票上市规则》有关规定，福建傲农生物科技集团股 份有限公司对公司及下属控股子公司（简称"公司"）2025 年 3 月 10 日至今新 ...

内容概要："9+5"产业是漳州经济高质量发展的主支撑。近年来，漳州市积极推进新型工业化融入全市 工业发展全过程，大力推动传统产业巩固优势、转型升级，培育壮大战略性新兴产业，前瞻布局未来产 业，厚植新质生产力发展沃土，着力构建具有漳州特色的现代化产业体系。市委市政府大力实施"千百 亿产业培育行动计划"，加快打造食品加工、石油化工等9个千亿级产业集群，以及电子信息、数字服务 等5个超五百亿产业集群，为加快培育新质生产力提供良好的基础，靶向施策助力民营经济大有可为。 在多重利好因素推动下，漳州市"9+5"产业规模持续壮大，产业创新力持续增强，核心竞争力不断提 升，园区载体不断夯实。2024年，"9+5"产业集群中工业九大产业合计增加值增长7.5%。2025年1-3月， 漳州市九大工业产业增加值增长8.8%。2024年期间，食品工业、石油化工、装备制造、建材家居、冶 金新材料、绿色纸业产业增加值增速呈正增长，医药健康、新能源、电子信息增加值增速为负增长。绿 色纸业同比增长19.9%、冶金新材料同比增长15.2%、石油化工同比增长14.2%。 上市企业：片仔癀（600436）、龙溪股份（600592）、漳州发展（000 ...

Summary of Key Points Core Viewpoint - The company, Fujian Aonong Biological Technology Group Co., Ltd., has announced its guarantee situation, detailing the amounts and conditions under which it provides guarantees to its subsidiaries and industry partners. Group 1: Guarantee Overview - The company plans to provide guarantees totaling up to 800 million yuan to industry chain partners, including suppliers and cooperative farmers [1] - The maximum guarantee amount for subsidiaries with an asset-liability ratio below 70% is set at 1.5 billion yuan, while for those above 70%, it is also 1.5 billion yuan [1] - The company’s wholly-owned and holding subsidiaries can provide guarantees of up to 500 million yuan for other subsidiaries with an asset-liability ratio below 70% and 1 billion yuan for those above 70% [1] Group 2: Progress on Guarantees - As of May 31, 2025, the total guarantee balance provided to 185 industry chain partners is 146.4893 million yuan [2] - The top five guarantees provided to cooperative farmers are as follows: - First: 5 million yuan, with a one-year term and no overdue payments - Second: 5 million yuan, with a one-year term and overdue payments - Third: 5 million yuan, with a one-year term and overdue payments - Fourth: 4 million yuan, with a one-year term and no overdue payments - Fifth: 3.8 million yuan, with a one-year term and overdue payments [2] Group 3: Total Guarantee Amounts - As of May 31, 2025, the total external guarantees provided by the company and its wholly-owned and holding subsidiaries amount to 1.225109 billion yuan, which is 47.74% of the company's latest audited net assets [4] - The guarantees provided to wholly-owned and holding subsidiaries total 1.4762398 billion yuan, representing 57.53% of the company's latest audited net assets [4] - The guarantees among subsidiaries amount to 680.4983 million yuan, accounting for 26.52% of the company's latest audited net assets [4]

福建傲农生物科技集团股份有限公司 2025 年 5 月公司担保情况的公告 证券代码：603363 证券简称：傲农生物 公告编号：2025-077 截至 2025 年 5 月 31 日，公司及下属子公司为产业链合作伙伴提供的担保余 额前五名的情况如下： 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、担保情况概述 福建傲农生物科技集团股份有限公司（以下简称"公司"或"本公司"）于 2025 年 3 月 28 日召开的第四届董事会第十二次会议和 2025 年 4 月 14 日召开的 2025 年第二次临时股东大会审议通过了《关于 2025 年度为产业链合作伙伴提供 担保的议案》、《关于 2025 年度公司及下属子公司相互提供担保的议案》，内 容包括： 1、同意公司及下属子公司 2025 年度为公司及下属子公司的下游客户、产业 链供应商、公司养殖放养业务的合作养户等产业链合作伙伴提供不超过 8 亿元的 担保。 2、同意公司及下属全资、控股子公司在 2024 年度继续相互提供担保，其中 公司为下属资产负债率低于 70%的子公司提供 ...

Core Points - The legal opinion letter confirms the compliance of the 2024 annual shareholders' meeting of Fujian Aonong Biological Technology Group Co., Ltd. with relevant laws and regulations [1][2][3] - The meeting was convened by the board of directors and followed the proper procedures for notification and voting [4][5][13] Group 1: Meeting Procedures - The notice for the 2024 annual shareholders' meeting was published 20 days prior, in accordance with the Company Law and Shareholders' Meeting Rules [2][4] - The meeting was held at the company's conference room, presided over by the chairman, Su Mingcheng, and utilized an online voting system [3][5] Group 2: Attendance and Voting - A total of 439 shareholders and their proxies attended the meeting, representing 859,421,183 shares, which is 39.2573% of the total voting shares [4][5] - The voting results indicated that all resolutions were passed with more than half of the voting rights present, and special resolutions received over two-thirds approval [7][9][13]